Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Nora N Bennani"'
Autor:
Jonas Paludo, Jose C. Villasboas, Yucai Wang, Thomas M. Habermann, Ivana N. Micallef, William R. Macon, Scott C. Lester, Patrick B. Johnston, Yi Lin, Thomas E. Witzig, Nora N Bennani, Robert M. Kraft, David J. Inwards, Carrie A. Thompson, Stephen M. Ansell, Luis F. Porrata, Gita Thanarajasingam, Grzegorz S. Nowakowski
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::640eb5a597371ae70d7a13b9dd6b6124
https://doi.org/10.1002/hon.2919/v2/response1
https://doi.org/10.1002/hon.2919/v2/response1
Autor:
Jonas Paludo, Yi Lin, Allison C. Rosenthal, Jose C. Villasboas, Mohamed A. Kharfan-Dabaja, Javier Munoz, Hemant S. Murthy, Radhika Bansal, Stephen M. Ansell, Madiha Iqbal, Thomas E. Witzig, Matthew J. Maurer, Matthew A. Hathcock, Yucai Wang, Grzegorz S. Nowakowski, Patrick B. Johnston, Arushi Khurana, Nora N Bennani, Januario E. Castro, Evandro D. Bezerra
Publikováno v:
Transplantation and Cellular Therapy. 28:S418-S419
Background Patients (pts) with aggressive B-cell non-Hodgkin lymphoma (NHL) progressing after anti-CD19 chimeric antigen receptor T (CART) cell therapy have poor prognosis and may benefit from new therapy options through clinical trials. However, in
Autor:
Marissa Z Powell, Kristin Mara, Radhika Bansal, Matthew Hathcock, Arushi Khurana, Nora N Bennani, Yucai Wang, Jonas Paludo, Jose C Villasboas, Stephen Ansell, Patrick B Johnston, Yi Lin, Jason N Barreto
Publikováno v:
Transplantation and Cellular Therapy. 28:S179-S180
Autor:
Arushi Khurana, Allison Rosenthal, Radhika Bansal, Matthew Hathcock, Adrienne Nedved, Yucai Wang, Jonas Paludo, Jose C Villasboas, Nora N Bennani, Patrick B Johnston, Stephen Ansell, Yi Lin
Publikováno v:
Transplantation and Cellular Therapy. 28:S197-S198
Autor:
B.J. Stish, Yi Lin, S. M. Ansell, Patrick B. Johnston, J. Villasboas Bisneto, Jonas Paludo, Yi Wang, Jennifer L. Peterson, Matthew A. Hathcock, Roman O. Kowalchuk, Arushi Khurana, Jason R. Young, Scott C. Lester, Radhika Bansal, William G. Breen, Nora N Bennani
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:S131-S132
Purpose/Objective(s) Chimeric antigen receptor T-cell (CAR-T) therapy is utilized for patients with active non-Hodgkin lymphoma (NHL) refractory to recent treatments, sometimes even requiring bridging therapy during CAR-T manufacturing to maintain cl
Autor:
Thomas M. Habermann, Stephen M. Ansell, Patrick B. Johnston, David J. Inwards, Jonas Paludo, Jose C. Villasboas, Ivana N. Micallef, Yucai Wang, Nora N Bennani, Carrie A. Thompson, Thomas E. Witzig, Luis F. Porrata, Gita Thanarajasingam, Nicole McLaughlin, Grzegorz S. Nowakowski
Publikováno v:
Blood. 138:2426-2426
Background: While extranodal involvement by mantle cell lymphoma (MCL) is relatively common, involvement of the central nervous system (CNS) is rare ( Methods: MCL pts with CNS involvement seen at Mayo Clinic between 1/1995-9/2020 were identified usi
Autor:
David Dingli, Prashant Kapoor, Matthew A. Hathcock, Yi Lin, Suzanne R. Hayman, Stephen M. Ansell, Kelsey L Haugen, Hassan B. Alkhateeb, Saad S. Kenderian, Mithun Vinod Shah, Morie A. Gertz, Radhika Bansal, Tuan A Truong, Jose C. Villasboas, Shaji Kumar, Nora N Bennani, Megan T Spychalla, Taxiarchis Kourelis, Jonas Paludo, Alli Louise McClanahan, Rahma Warsame, Mustaqeem A. Siddiqui, Adam Holland, Yucai Wang, Tufia C. Haddad, Patrick B. Johnston, Arushi Khurana
Publikováno v:
Blood. 138:568-568
Introduction: Chimeric antigen receptor T-cell (CAR-T) therapy is an effective treatment that has transformed hematologic malignancy management. However, its significant short-term toxicities, mainly cytokine release syndrome (CRS) and neurotoxicity,
Autor:
Jason R. Young, Caroline J. Davidge-Pitts, Matthew J. Koster, Robert Vassallo, Nora N Bennani, Ronald S. Go, Jay H. Ryu, Saurabh Zanwar, Aldo A. Acosta-Medina, Mithun Vinod Shah, Karen L. Rech, Aishwarya Ravindran, Gaurav Goyal, Jithma P. Abeykoon, W. Oliver Tobin
Publikováno v:
Blood. 138:1506-1506
INTRODUCTION Rosai-Dorfman disease (RDD) is a rare histiocytic disorder associated with histiocytes expressing high level of macrophage colony stimulating factor receptor (c-fms). Mutations in mitogen-activated protein kinase (MAPK) pathway have been
A Multi-Institutional Retrospective Analysis of T-Cell Lymphomas with Central Nervous System Relapse
Autor:
Nivetha Ganesan, Kitsada Wudhikarn, Adam J. Olszewski, Daniel J. Landsburg, James N. Gerson, Steven M. Horwitz, Neha Mehta-Shah, Robert N. Stuver, Priyanka Pullarkat, Brad Haverkos, Julio C. Chavez, Rahul S. Bhansali, Stephen J. Schuster, Steven R. Hwang, Swami P. Iyer, Pamela B. Allen, Caroline Goldin, Hayder Saeed, Lubomir Sokol, Sunita D. Nasta, Elise A. Chong, Jakub Svoboda, Rishab Prakash, Stefan K. Barta, Nora N Bennani
Publikováno v:
Blood. 138:1382-1382
Introduction Central nervous system (CNS) relapse (CNSr) in patients with aggressive non-Hodgkin lymphoma (NHL) occurs uncommonly (estimated incidence 5%) but carries a high morbidity and mortality. Studies have identified risk factors for CNSr such
Autor:
Jithma P. Abeykoon, Gaurav Goyal, Mithun Vinod Shah, Aishwarya Ravindran, Aldo A. Acosta-Medina, Saurabh Zanwar, Karen L. Rech, Diana Morlote, Nora N Bennani, Jonathan Schwartz, Ronald S. Go
Publikováno v:
Blood. 138:2582-2582
Background: Activation of extracellular-signal regulated kinase (ERK) is almost universal in histiocytic disorders and is driven by genomic alterations in the mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinases (PI3K) pathways. Whi